Worldwide Healthcare Trust: why it’s time to buy

TL;DR

Investing in transformative healthcare companies for long-term growth potential.

Transcript

hello with me today i have sven borrow co-manager of the worldwide healthcare trust i mean there are a couple of companies that really stand out looking at the latest fact sheet marathi therapeutics and horizon and they're now in your top 10 holdings following a you know big surge in the share price over the past few months can you tell us just a l... Read More

Key Insights

• 🎁 Marathi and Horizon present potential for outperforming benchmarks with transformative drugs.
• 🥹 Vertex Pharmaceuticals and Boston Scientific are long-term holdings due to their one decision stock nature.
• 💪 Healthcare sector valuation to potentially rebound post-presidential election with strong innovative trends.
• 📈 Retail investors advised to focus on transformative companies and avoid chasing trends or events.
• 🤩 FDA's support for innovation and fast regulatory approval key themes in healthcare sector.
• 😷 Healthcare innovation across various areas like gene therapy, targeted cancer therapies, and med tech offers long-term growth potential.

Questions & Answers

Q: What are the key themes behind the investment in Marathi and Horizon?

Marathi focuses on transformative cancer drugs, while Horizon reinvented with new drugs like Cristexa and Tepetsa, leading to accelerated growth.

Q: Are there any one decision stocks in the healthcare sector in your portfolio?

Vertex Pharmaceuticals and Boston Scientific are considered one decision stocks due to transformative drugs and strong management leading to long-term success.

Q: What major trends do you foresee in global healthcare for the next few years?

Secular themes include potential impact from the presidential election, M&A activity, FDA support for innovation, and overall strong growth in healthcare innovation.

Q: Is it simple for retail investors to get involved in biotech and healthcare stocks? Any advice for them?

It's challenging for retail investors without scientific knowledge. Focus on transformative companies and avoid chasing trends or binary events for successful investing in healthcare.

Summary & Key Takeaways

• Marathi Therapeutics and Horizon are top holdings due to their potential for outperforming benchmarks.

• Marathi focuses on a transformative cancer drug with acquisition potential, while Horizon reinvented with new drugs.

• Vertex Pharmaceuticals and Boston Scientific are long-term one decision stocks in biotech and med tech sectors.